IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Sun Yat-sen University
Chinese University of Hong Kong
National Institutes of Health Clinical Center (CC)
Southwest Hospital, China
Chinese University of Hong Kong
University of Aarhus
Sohag University
American College of Radiology Imaging Network
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Seoul National University Hospital
M.D. Anderson Cancer Center
Fudan University
Assistance Publique - Hôpitaux de Paris
The Second People's Hospital of GuangDong Province
National Institutes of Health Clinical Center (CC)